LON:GENF Genflow Biosciences (GENF) Share Price, News & Analysis GBX 0.71 +0.01 (+1.72%) As of 04:08 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsBuy This Stock About Genflow Biosciences Stock (LON:GENF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Genflow Biosciences alerts:Sign Up Key Stats Today's Range 0.65▼ 0.7550-Day Range 0.67▼ 0.9052-Week Range 0.55▼ 2.40Volume716,303 shsAverage Volume4.04 million shsMarket Capitalization£2.42 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs. The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results. Read More Receive GENF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genflow Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address GENF Stock News HeadlinesGenflow Biosciences PLC (GENF)April 6, 2023 | investing.comCompanies Like Genflow Biosciences (LON:GENF) Can Afford To Invest In GrowthApril 6, 2023 | finance.yahoo.comSee More Headlines GENF Stock Analysis - Frequently Asked Questions How have GENF shares performed this year? Genflow Biosciences' stock was trading at GBX 1.80 at the beginning of 2025. Since then, GENF shares have decreased by 61.2% and is now trading at GBX 0.70. How were Genflow Biosciences' earnings last quarter? Genflow Biosciences plc (LON:GENF) released its quarterly earnings results on Wednesday, April, 30th. The company reported ($0.47) earnings per share (EPS) for the quarter. Genflow Biosciences had a negative trailing twelve-month return on equity of 208.12% and a net margin of 778.46%. How do I buy shares of Genflow Biosciences? Shares of GENF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Genflow Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Genflow Biosciences investors own include Aehr Test Systems (AEHR), Advanced Micro Devices (AMD), ARM (ARM), Medical Properties Trust (MPW), NIO (NIO), NVIDIA (NVDA) and PayPal (PYPL). Company Calendar Last Earnings4/30/2025Today8/04/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:GENF CIKN/A Webgenflowbio.com Phone44 32 4774 95881FaxN/AEmployees5Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (0.53) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£1.76 million Net Margins778.46% Pretax MarginN/A Return on Equity-208.12% Return on Assets-58.66% Debt Debt-to-Equity RatioN/A Current Ratio3.09 Quick Ratio20.20 Sales & Book Value Annual Sales-£226.19 thousand Price / Sales-10.70 Cash FlowGBX 0.24 per share Price / Cash Flow3.00 Book ValueGBX 0.25 per share Price / Book2.86Miscellaneous Outstanding Shares340,919,077Free FloatN/AMarket Cap£2.42 million OptionableNot Optionable Beta2.37 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (LON:GENF) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWall Street Laughed. Now They're Buying.For six months, I’ve been pounding the table on a major gold miner—while Twitter pundits laughed. But now, the...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Create New Advertiser | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genflow Biosciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Genflow Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.